Alpha Teknova (NASDAQ:TKNO) Trading 0.7% Higher – Should You Buy?

Alpha Teknova, Inc. (NASDAQ:TKNO)’s stock price was up 0.7% on Friday . The stock traded as high as $7.93 and last traded at $7.33. Approximately 232,229 shares traded hands during mid-day trading, an increase of 0% from the average daily volume of 231,766 shares. The stock had previously closed at $7.28.

Alpha Teknova Price Performance

The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.94 and a current ratio of 4.73. The stock has a market capitalization of $390.76 million, a price-to-earnings ratio of -9.91 and a beta of 0.35. The business’s 50 day simple moving average is $5.96 and its 200-day simple moving average is $3.85.

Alpha Teknova (NASDAQ:TKNO) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.04). The business had revenue of $9.58 million for the quarter, compared to analyst estimates of $9.30 million. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. During the same quarter in the prior year, the firm posted ($0.34) earnings per share. Research analysts anticipate that Alpha Teknova, Inc. will post -0.54 earnings per share for the current year.

Institutional Trading of Alpha Teknova

A number of institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC increased its position in shares of Alpha Teknova by 24.4% during the 3rd quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock valued at $911,000 after purchasing an additional 36,914 shares during the period. State Street Corp boosted its stake in Alpha Teknova by 249.3% during the third quarter. State Street Corp now owns 76,645 shares of the company’s stock valued at $371,000 after buying an additional 54,700 shares in the last quarter. Point72 Asset Management L.P. acquired a new position in Alpha Teknova during the third quarter worth about $1,483,000. Roubaix Capital LLC bought a new stake in Alpha Teknova in the third quarter worth about $2,015,000. Finally, Conestoga Capital Advisors LLC lifted its holdings in Alpha Teknova by 81.6% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 453,899 shares of the company’s stock valued at $622,000 after acquiring an additional 203,950 shares during the last quarter. 13.81% of the stock is owned by institutional investors and hedge funds.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.